Knijnenburg TA, Wang L, Zimmermann MT, et al. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018;23(1):239-254.e6. doi:10.1016/j.celrep.2018.03.076
Huang K lin, Mashl J, Wu Y, et al. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 2018;173(2):355-370.e14. doi:10.1016/j.cell.2018.03.039
Merkle FT, Ghosh S, Kamitaki N, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545(7653):229-233. doi:10.1038/nature22312
Cuomo CA, Shea T, Yang B, Rao R, Forche A. Whole Genome Sequence of the Heterozygous Clinical Isolate 81-B-5. G3 (Bethesda). 2017;7(9):2883-2889. doi:10.1534/g3.117.043547
Rhodes J, Desjardins CA, Sykes SM, et al. Tracing Genetic Exchange and Biogeography of var. at the Global Population Level. Genetics. 2017;207(1):327-346. doi:10.1534/genetics.117.203836
Ene IV, Farrer RA, Hirakawa MP, Agwamba K, Cuomo CA, Bennett RJ. Global analysis of mutations driving microevolution of a heterozygous diploid fungal pathogen. Proc Natl Acad Sci U S A. 2018;115(37):E8688-E8697. doi:10.1073/pnas.1806002115
Sade-Feldman M, Jiao YJ, Chen JH, et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat Commun. 2017;8(1):1136. doi:10.1038/s41467-017-01062-w
Lin WM, Baker AC, Beroukhim R, et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 2008;68(3):664-73. doi:10.1158/0008-5472.CAN-07-2615
Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450(7171):893-8. doi:10.1038/nature06358
Dutt A, Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Curr Opin Oncol. 2007;19(1):43-9. doi:10.1097/CCO.0b013e328011a8c1